The company has won Start-up of the Year at the Cambridge Independent Science and Technology Awards.
CEO Sarah Howell is nominated as CEO of the Year at the Cambridge Independent Science and Technology Awards.
Olaparib - discovered by Prof Steve Jackson’s team at the University of Cambridge - is available with bevacizumab under the Cancer Drugs Fund.
The US government has struck a $231.8m deal for the delivery of 8.5 million tests.
The Cambridge-based life science research tools provider said demand has yet to return to normal.
Its report says take-up of office and lab space returned to trend levels in the second half of 2020.
The lineup for the inaugural online Cambridge Festival has gone live.
They will get seed funding, access to facilities and lab space.
Revenues rose 10 per cent to $26.62billion.
ReCoVa-19 is aiding recruitment through its testing programme.
It raises Series C financing to $60m
The Cambridge-based digital health technology company will supply at-home DNA testing kits for 3,000 patients.
It focuses on small molecule SHP2 inhibitor candidates.
The deal is expected to be completed in the first half of 2021.
It is designed to handle the massive data demands for the life science industry and explosion in artificial intelligence.
They were initially licensed to Allergan.